S. Foster

发表

Progressive Region-Specific De Novo Methylation of the p16 CpG Island in Primary Human Mammary Epithelial Cell Strains during Escape from M0 Growth Arrest

Brian J. Reid, D. Wong, B. Reid, 1999, Molecular and Cellular Biology.

Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7.

G. Demers, D. Galloway, C. Halbert, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Multiple mechanisms determine the order of APC / C substrate degradation in mitosis

Norman E. Davey, David O. Morgan, N. Davey, 2014 .

S/GSK1349572 is a Potent Next Generation HIV Integrase Inhibitor

E. Garvey, S. Foster, T. Fujiwara, 2009 .

Selection of diverse and clinically relevant integrase inhibitor-resistant human immunodeficiency virus type 1 mutants.

E. Garvey, T. Seki, S. Foster, 2008, Antiviral research.

Secondary mutations in viruses resistant to HIV-1 integrase inhibitors that restore viral infectivity and replication kinetics.

E. Garvey, T. Seki, S. Foster, 2009, Antiviral research.

The APC/C subunit Mnd2/Apc15 promotes Cdc20 autoubiquitination and spindle assembly checkpoint inactivation.

D. Morgan, S. Foster, 2012, Molecular cell.

Structural basis of guanine nucleotide exchange mediated by the T-cell essential Vav1.

Greg L. Hura, J. Tainer, P. Kuhn, 2008, Journal of molecular biology.

actinomycin D-induced growth arrest. correlates with their ability to abrogate proteins to target p53 for degradation in vivo The ability of human papillomavirus E6

G. Demers, D. Galloway, S. Foster, 2013 .

JCB_201402041 23..40

Norman E. Davey, N. Davey, D. Morgan, 2014 .

Cell cycle checkpoint control is bypassed by human papillomavirus oncogenes.

G. Demers, D. Galloway, C. Halbert, 1994, Cold Spring Harbor symposia on quantitative biology.

Human papillomavirus type 16 E7 alleviates a proliferation block in early passage human mammary epithelial cells.

D. Galloway, S. Foster, 1996, Oncogene.

Progressive Region-Speciﬁc De Novo Methylation of the p16 CpG Island in Primary Human Mammary Epithelial Cell Strains during Escape from M 0 Growth Arrest

D. Wong, B. Reid, D. Galloway, 1999 .

The E6 protein of human papillomavirus type 16 functions as a transcriptional repressor in a mechanism independent of the tumor suppressor protein, p53.

D. Galloway, S. Foster, B. Etscheid, 1994, Virology.

The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore.

E. Garvey, S. Foster, J. Jeffrey, 2009, Bioorganic & medicinal chemistry letters.

1,3,4-Oxadiazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 2: SAR of the C5 position.

E. Garvey, S. Foster, J. Jeffrey, 2009, Bioorganic & medicinal chemistry letters.

Synthesis and antiviral activity of 7-benzyl-4-hydroxy-1,5-naphthyridin-2(1H)-one HIV integrase inhibitors.

E. Garvey, S. Foster, T. Fujiwara, 2009, Journal of medicinal chemistry.

Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells

T. Kiyono, D. Galloway, J. McDougall, 1998, Nature.

In Vitro Antiretroviral Properties of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor

Shigeru Miki, Akihiko Sato, Kevin W. Brown, 2010, Antimicrobial Agents and Chemotherapy.

Telomerase activation by the E6 gene product of human papillomavirus type 16

J. McDougall, S. Foster, A. Klingelhutz, 1996, Nature.

Naphthyridinone (NTD) integrase inhibitors 4. Investigating N1 acetamide substituent effects with C3 amide groups.

E. Garvey, S. Foster, T. Fujiwara, 2014, Bioorganic & medicinal chemistry letters.

Naphthyridinone (NTD) integrase inhibitors: N1 protio and methyl combination substituent effects with C3 amide groups.

E. Garvey, S. Foster, T. Fujiwara, 2013, Bioorganic & medicinal chemistry letters.

Combining symmetry elements results in potent naphthyridinone (NTD) HIV-1 integrase inhibitors.

E. Garvey, S. Foster, T. Fujiwara, 2011, Bioorganic & medicinal chemistry letters.

The Naphthyridinone GSK364735 Is a Novel, Potent Human Immunodeficiency Virus Type 1 Integrase Inhibitor and Antiretroviral

E. Garvey, S. Foster, T. Fujiwara, 2007, Antimicrobial Agents and Chemotherapy.

Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis

G. Demers, D. Galloway, K. L. Donaldson, 1996, Nature Medicine.

Identifying transcriptional programs underlying cancer drug response with TraCe-seq

Z. Modrušan, Matthew T. Chang, S. Malek, 2021, Nature Biotechnology.

Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2.

P. Stephens, G. Manning, Ayşegül Özen, 2016, Cancer cell.

Inactivation of p16 in Human Mammary Epithelial Cells by CpG Island Methylation

D. Wong, M. Barrett, D. Galloway, 1998, Molecular and Cellular Biology.

The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest

G. Demers, D. Galloway, S. Foster, 1994, Journal of virology.

Carbamoyl pyridone HIV-1 integrase inhibitors 3. A diastereomeric approach to chiral nonracemic tricyclic ring systems and the discovery of dolutegravir (S/GSK1349572) and (S/GSK1265744).

E. Garvey, T. Seki, S. Foster, 2013, Journal of medicinal chemistry.

Ternary complex dissociation kinetics contribute to mutant-selective EGFR degradation.

Ivana Yen, S. Malek, F. Shanahan, 2023, Cell chemical biology.

Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant Tumors.

Dhara N. Amin, R. Neve, Ivana Yen, 2018, Cancer cell.

Tissue-Specific Mutations in BRAF and EGFR Necessitate Unique Therapeutic Approaches.

S. Malek, C. Klijn, S. Foster, 2016, Trends in cancer.

Use of amphotropic retroviruses expressing human papillomavirus 16 E6 and E7 to determine the consequences of acute expression of the viral oncogenes and to establish immortalized human cell lines

G. Demers, D. Galloway, J. McDougall, 1995 .

Ubiquitination of Cdc20 by the APC Occurs through an Intramolecular Mechanism

D. Toczyski, D. Morgan, S. Foster, 2011, Current Biology.

Remedial strategies in structural proteomics: expression, purification, and crystallization of the Vav1/Rac1 complex.

E. Chien, P. Kuhn, J. Chrencik, 2007, Protein expression and purification.

Identifying transcriptional programs underlying cancer drug response with TraCe-seq

Z. Modrušan, Matthew T. Chang, S. Malek, 2021, Nature Biotechnology.

Catalysis of lysine 48-specific ubiquitin chain assembly by residues in E2 and ubiquitin.

D. Morgan, S. Foster, Monica C. Rodrigo-Brenni, 2010, Molecular cell.

Targeted degradation via direct 26S proteasome recruitment

C. Ciferri, N. Popovych, I. Wertz, 2022, Nature Chemical Biology.

The RAS/MAPK Axis Gets Stressed Out.

S. Malek, S. Foster, 2016, Molecular cell.

Multiple mechanisms determine the order of APC/C substrate degradation in mitosis

Norman E. Davey, D. Morgan, S. Foster, 2014, The Journal of cell biology.